Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.09B | 13.67B | 14.43B | 16.27B | 17.73B | 19.58B | Gross Profit |
2.46B | 1.69B | 3.18B | 3.58B | 3.64B | 4.68B | EBIT |
622.00M | 466.00M | -659.00M | 1.60B | -397.00M | 1.57B | EBITDA |
1.61B | 1.81B | 942.00M | 3.17B | 3.07B | -2.81B | Net Income Common Stockholders |
-75.00M | 91.00M | -566.00M | 718.00M | -146.00M | -5.36B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.72B | 1.22B | 1.86B | 2.67B | 2.97B | 3.68B | Total Assets |
13.03B | 13.87B | 15.85B | 20.14B | 22.04B | 26.01B | Total Debt |
864.00M | 4.87B | 5.37B | 6.17B | 6.97B | 11.49B | Net Debt |
-859.00M | 3.64B | 3.51B | 3.50B | 4.00B | 7.81B | Total Liabilities |
9.78B | 10.80B | 12.03B | 14.76B | 16.73B | 20.88B | Stockholders Equity |
2.99B | 2.81B | 3.82B | 5.38B | 5.31B | 5.13B |
Cash Flow | Free Cash Flow | ||||
463.00M | 756.00M | 960.00M | 952.00M | -391.00M | 1.76B | Operating Cash Flow |
1.36B | 1.36B | 1.42B | 1.50B | 124.00M | 2.35B | Investing Cash Flow |
-467.00M | -491.00M | -635.00M | -60.00M | 4.67B | -2.14B | Financing Cash Flow |
-867.00M | -1.49B | -1.51B | -1.82B | -5.48B | 657.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $41.42B | 18.58 | 15.55% | 1.44% | 1.98% | 7.16% | |
76 Outperform | $216.28B | 28.99 | 27.10% | 1.60% | 2.75% | 10.53% | |
75 Outperform | $80.41B | 24.69 | 29.99% | 2.10% | 3.08% | 11.92% | |
68 Neutral | $33.55B | 30.07 | 14.73% | 1.91% | -3.41% | 67.87% | |
67 Neutral | $234.79B | 39.40 | 24.14% | 2.64% | 1.45% | -20.56% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% | |
47 Neutral | $3.26B | 267.98 | -2.51% | ― | -5.65% | 78.20% |